Recombinant Human FIGN Protein，His

FIGN (Fidgetin-like 1) is a member of the AAA+ ATPase family, which plays a crucial role in cellular activities such as cytoskeletal dynamics, organelle transport, and cellular signaling. The study of FIGN and its recombinant protein has garnered increasing interest due to its potential implications in various physiological and pathological processes, including developmental disorders and cancer. FIGN is known for its fidgetin-like activity in regulating the stability and organization of microtubules and actin filaments, key components of the cytoskeleton. Understanding the functional mechanisms of FIGN at the molecular level is vital, as its dysregulation has been associated with several diseases. Research on recombinant FIGN proteins has enabled scientists to investigate their biochemical properties, interactions with other cellular components, and effects on cellular processes. By employing techniques such as protein expression systems, purification methods, and functional assays, researchers aim to unravel the specific roles of FIGN in cellular architecture and dynamics. This has the potential to shed light on its therapeutic value, particularly in conditions where cytoskeletal abnormalities are prevalent. Furthermore, the ability to produce and manipulate recombinant FIGN allows for the exploration of its structure-function relationships, paving the way for innovative strategies in disease treatment and prevention. Overall, the exploration of FIGN recombinant proteins represents a promising avenue for advancing our understanding of cellular mechanisms and developing targeted therapies for diseases linked to cytoskeletal dysfunction.